EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission

Lauren A George iD, Harris T Feldman, Madeline Alizadeh, Ameer Abutaleb, Samantha Zullow, Ashley Hine, Kristen Stashek, Suparna Sarkar, Katherine Sun, David Hudesman, Jordan Axelrad iD, Raymond K Cross iD

Crohn's & Colitis 360 · 01.10.2023 · 5 (4)

DOI: 10.1093/crocol/otad059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crohn's & Colitis 360, online erschienen am 18.10.2023. Verfasst von Lauren A George und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Madeline Alizadeh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In ulcerative colitis (UC), endoscopic improvement, defined as a Mayo Endoscopic Score (MES) of 0 or 1, is a target of treatment. The aim of our study was to evaluate the risk of clinical relapse between patients with an MES of 0 or 1 and determine if histologic activity using the Robarts Histopathologic Index (RHI) was predictive of clinical relapse.

Methods

UC patients with an MES score of 0 or 1, no prior colectomy, and at least 1 year of outpatient follow-up after colonoscopy were included. Demographic, clinical characteristics, and clinical relapse were retrospectively collected. Biopsy specimens were read by a gastrointestinal pathologist. Primary outcome was defined as a composite of relapse requiring change in medical therapy, new steroid use, UC-related hospitalization, and/or colectomy.

Results

Four hundred and forty-five UC patients were identified. Ninety-five percent of patients with MES 0 were in histologic remission by the RHI whereas only 35% of patients with MES 1 were in histologic remission. Twenty-six percent of patients experienced a clinical relapse; patients with MES 1 or RHI > 3 were significantly more likely to relapse (P < .01) compared to patients with MES 0 or RHI ≤ 3. When patients were stratified into 4 groups (MES 0, RHI ≤ 3; MES 0, RHI > 3; MES 1, RHI ≤ 3; MES 1, RHI > 3) and adjusted for age and sex, RHI > 3 was predictive of relapse (P = .008).

Conclusions

UC patients with endoscopic improvement have a high rate of clinical relapse over time. Histologic activity is a predictor of clinical relapse.

Schlagwörter

Stichwörter der Autor:innen

histologyrelapseremissionulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Department of Medicine, Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA, USA.
  • Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • University of Connecticut School of Medicine, Farmington, CT, USA.
  • Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Lauren A George, Jordan Axelrad, Raymond K Cross

Förderung

  • NIDDK NIH HHS
  • Madeline Alizadeh

Zitieren

APA

George, L. A., Feldman, H. T., Alizadeh, M., Abutaleb, A., Zullow, S., Hine, A., Stashek, K., Sarkar, S., Sun, K., Hudesman, D., Axelrad, J., & Cross, R. K. (2023). Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission. Crohn's & Colitis 360, 5(4). https://doi.org/10.1093/crocol/otad059

Vancouver

George LA, Feldman HT, Alizadeh M, Abutaleb A, Zullow S, Hine A, et al. Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission. Crohn's & Colitis 360. 2023;5(4). doi:10.1093/crocol/otad059

BibTeX
@article{George2023,
  author = {George, Lauren A and Feldman, Harris T and Alizadeh, Madeline and Abutaleb, Ameer and Zullow, Samantha and Hine, Ashley and Stashek, Kristen and Sarkar, Suparna and Sun, Katherine and Hudesman, David and Axelrad, Jordan and Cross, Raymond K},
  title = {Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission},
  journal = {Crohn's & Colitis 360},
  year = {2023},
  volume = {5},
  number = {4},
  doi = {10.1093/crocol/otad059}
}
Kostenlos starten →